Evolving Standards in Biologics Development: What’s New in PDA TR 56 (2026) on Level of GMPs Needed and Why It Matters for Startups
As a CMC and quality expert with over two decades in the biopharma industry, I've had countless conversations with leaders at small biotech companies and…
